DermaBio

DermaBio is a precision medicine company developing a skin biomarker platform to improve diagnosis, monitoring, and treatment selection for chronic and autoimmune inflammatory diseases. Founded in 2022, the company applies dermatological biomarkers to enable more targeted therapeutic decisions.